Boston Trust Walden Corp Increases Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Boston Trust Walden Corp grew its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,253,815 shares of the medical device company's stock after acquiring an additional 19,038 shares during the period. Cooper Companies comprises 1.0% of Boston Trust Walden Corp's investment portfolio, making the stock its 15th biggest holding. Boston Trust Walden Corp owned approximately 0.63% of Cooper Companies worth $138,346,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Benjamin F. Edwards & Company Inc. grew its holdings in shares of Cooper Companies by 248.6% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company's stock valued at $25,000 after purchasing an additional 174 shares in the last quarter. Innealta Capital LLC acquired a new position in shares of Cooper Companies in the second quarter valued at approximately $25,000. Covestor Ltd grew its holdings in shares of Cooper Companies by 305.9% in the first quarter. Covestor Ltd now owns 276 shares of the medical device company's stock valued at $28,000 after purchasing an additional 208 shares in the last quarter. Crewe Advisors LLC grew its holdings in shares of Cooper Companies by 286.4% in the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company's stock valued at $30,000 after purchasing an additional 252 shares in the last quarter. Finally, Tortoise Investment Management LLC grew its holdings in shares of Cooper Companies by 75.4% in the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company's stock valued at $34,000 after purchasing an additional 169 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now owns 44,696 shares of the company's stock, valued at approximately $4,714,534.08. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at $520,488.54. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock worth $27,637,427 in the last 90 days. Company insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

COO has been the subject of a number of research reports. Wells Fargo & Company lifted their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the company an "overweight" rating in a report on Thursday, August 29th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Thursday, August 29th. Stifel Nicolaus reiterated a "buy" rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Piper Sandler boosted their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a report on Thursday, August 29th. Finally, Jefferies Financial Group upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and boosted their price target for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $115.00.

Cooper Companies Stock Up 0.5 %

Shares of Cooper Companies stock traded up $0.52 during trading hours on Friday, hitting $107.82. The company had a trading volume of 3,270,373 shares, compared to its average volume of 1,128,228. The company has a market cap of $21.47 billion, a P/E ratio of 63.42, a price-to-earnings-growth ratio of 2.56 and a beta of 0.98. The company's 50-day moving average is $105.73 and its two-hundred day moving average is $96.72. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts' consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to analysts' expectations of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. Cooper Companies's quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.84 EPS. Analysts anticipate that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.